Sequenom (SQNM) says it's completed its private offering of $130M aggregate principal amount of...

|By:, SA News Editor

Sequenom (SQNM) says it's completed its private offering of $130M aggregate principal amount of 5% convertible senior notes due 2017. The company plans to use the proceeds to fund the commercialization of the MaterniT21 PLUS laboratory-developed test, as well as for other general corporate purposes.